AzTrials
AzTrials

Sleep DisturbanceTAPASNCT04163003

Targeted Intervention for Insufficient Sleep Among Typically-Developing Adolescents

A study testing Targeted Approaches for Promoting Adolescent Sleep (TAPAS) and Sleep Monitoring Only in people with Sleep Disturbance, run by University of Pittsburgh at 1 site in United States.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The overall aim of Dr. Levenson's research proposal is to test the acceptability, feasibility, and preliminary outcomes of a sleep promotion program delivered to 13-15 year olds who report insufficient sleep. Dr. Read more about this study

Who is it for?
Ages 13 to 15 yearsHealthy volunteers can take part
Conditions the study is for
Sleep Disturbance
What is being tested?
Targeted Approaches for Promoting Adolescent Sleep (TAPAS) and Sleep Monitoring Only
Could I receive a placebo?
No, everyone receives an active treatment
How many people
82 participants
Where
1 siteUnited States
Study dates
24 Oct 2019to 25 Aug 2022
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 13 to 15 years
  • All sexes
  • Healthy volunteers accepted
  • Child

Who may be able to join

  • ages 13-15;
  • sufficient sleep (>7.5 hours of sleep);
  • willing/able to provide informed assent/consent.

Who cannot join

  • Evidence of mental retardation, pervasive developmental disorder, or organic central nervous system disorder will exclude potential participants;
  • unstable medical conditions;
  • use of psychotropic medications or medications known to impact sleep;
  • adolescent pregnancy;
  • clinical levels of psychopathology, except for youth with a sole diagnosis of gender dysphoria;
  • current sleep disorders except for sleep-onset insomnia;
Show all 17Show fewer
  • extreme evening preference; and
  • Currently living >1 hour outside of the greater Pittsburgh region.
  • Sufficient Sleepers:
  • Evidence of mental retardation, pervasive developmental disorder, or organic central nervous system disorder;
  • unstable medical conditions;
  • use of psychotropic medications or medications known to impact sleep;
  • adolescent pregnancy;
  • clinical levels of psychopathology, except for youth with a sole diagnosis of gender dysphoria;
  • current sleep disorders except for sleep-onset insomnia;
  • extreme evening preference; and
  • Currently living >1 hour outside of the greater Pittsburgh region.

Trial locations and contacts

1 site in 1 country.

United States1 site
  • University of Pittsburgh

    Pittsburgh, Pennsylvania, 15213

Other trials in United States

About this study

The overall aim of Dr. Levenson's research proposal is to test the acceptability, feasibility, and preliminary outcomes of a sleep promotion program delivered to 13-15 year olds who report insufficient sleep. Dr. Levenson will examine the feasibility and acceptability of the program through a randomized pilot trial (n=40) that uses a two-period, wait-list control design. Then, Dr. Levenson will test whether the program is associated with changes in sleep, motivation, and four outcome domains: academic functioning, attention, risk behavior, and affect. Such a broadly relevant program has the potential for enormous public health impact by improving sleep and facilitating healthy development across a range of domains among typically-developing adolescents who are highly vulnerable to adverse consequences.

Read the detailed description

General Description:

This study has two sub-studies: one for youth who experience behaviorally insufficient sleep syndrome (BISS) and one for youth who obtain sufficient sleep. This includes a randomized controlled trial for youth who obtain insufficient sleep (BISS), and a universal education (UE) only intervention for youth who obtain sufficient sleep.

All participants will complete a pre-consent screen. Those with sufficient sleep will complete consent/assent and a full screening assessment, and they will watch a sleep education video (UE). If eligible for the sufficient sleeper study, the full screening assessment will serve as a baseline assessment as well. Participants will complete a follow-up assessment about one month later.

Those who pre-screen as insufficient sleepers will complete consent/assent, complete a full screening process, and watch a sleep education video (UE). Those who remain eligible after the full screening process will complete a baseline assessment. Then, youth will be randomized to the TAPAS intervention or to a wait-list control (monitoring only). After completing the post-period 1 follow-up assessment, those in the wait-list control group will switch to the other arm, via a cross-over design. Participants in the intervention-first group will continue to receive the intervention iin Period 2 after post-period 1. After this period, participants will complete the post-period 2 follow-up assessment.

Detailed Description:

Participants. Youth ages 13-15 will be recruited through various methods (e.g., social media advertising, University research registry, flyers, email listservs and online magazines, and from the waiting room of the Children's Hospital of Pittsburgh Center for Adolescent and Young Adult Health (CAYAH)). Among those screened, the investigators will deliver universal education about sleep and conduct baseline and follow-up assessments among n=35 sufficient sleepers. Investigators will randomize n=50 with insufficient sleep to the TAPAS intervention or wait-list control (monitoring only). Overall, investigators plan to collect complete data on n=40 participants, after attrition.

Baseline assessments will include: measures of sleep (sleep diary and actigraphy), academic functioning, attention, affect, motivation, and risk behavior.

TAPAS Intervention. Program goals are to increase knowledge about healthy sleep practices, to increase sleep duration by going to bed earlier (sleep extension), and to increase regularity in sleep timing over the week by limiting oversleeping on the weekends. During the 45-60 minute intervention session, the youth and clinician will discuss the youth's sleep timing and quality and explore the youth's attitudes and social influences on sleep. The clinician will develop discrepancies between current sleep behavior and the youth's values and goals.

It is proposed that the 4-8-week text messaging/web-based portion of the intervention will begin immediately after the clinician session. Participants will receive twice-weekly summaries of their sleep based on diary entries. Participants will then be asked via the web if they'd like to modify their sleep, providing them with autonomy in their answer. Investigators will rely on strategies for extending and regularizing sleep.

Wait-List Control (monitoring only) Condition. The wait-list is proposed to last half the duration as the targeted intervention (4 vs 8 weeks). Participants will monitor sleep with the sleep diary, but they will not receive feedback or any other information on their sleep.

Participants will repeat the baseline assessments and 7 days of actigraphy at the end of Period 1 and at the end of Period 2 (only those randomized to Wait-List Control will cross-over to TAPAS intervention for Period 2).

Follow-up assessments will include: measures of sleep (sleep diary and actigraphy), academic functioning, attention, affect, motivation, and risk behavior.

Being tested
Targeted Approaches for Promoting Adolescent Sleep (TAPAS), Sleep Monitoring Only
Medical subject headings
Parasomnias

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Targeted Approaches for Promoting Adolescent Sleep (TAPAS)Behavioural

    Also called TAPAS

    The targeted intervention is a three part sleep program, involving a 2- minute psychoeducation video, an in-person session with a clinician focusing on sleep, and web-based goal setting related to sleep behaviors. Intervention approaches to promoting adolescent sleep and reducing insufficient sleep use a motivational interviewing style, rooted in cognitive-behavioral strategies for improving sleep.

  • Sleep Monitoring OnlyBehavioural

    Participants will monitor sleep with sleep diary, but they will not receive feedback or any other information on to sleep.

Study groups in NCT04163003
Study groupRoleWhat they receive
TAPASExperimentalParticipants will participate in the TAPAS intervention, which will consist of one in-person engagement session with a therapist and 8 weeks of web-based automated intervention prompts. The program will utilize empirically supported approaches for promoting sleep health, delivered in-person and via text-message, focusing on: tailored psychoeducation, motivation and efficacy to change sleep, extending sleep duration, and regularizing sleep timing across the week.
Receives: Behavioral: Targeted Approaches for Promoting Adolescent Sleep (TAPAS)
Sleep monitoring only, then TAPASExperimentalParticipants will participate in sleep monitoring only first, then participate in the TAPAS intervention. First, participants will monitor sleep with sleep diary, but they will not receive feedback or any other information on to sleep.TAPAS will consist of one engagement session with a therapist and 4 weeks of web-based automated intervention prompts. The program will utilize empirically supported approaches for promoting sleep health, delivered in-person and via text-message, focusing on: tailored psychoeducation, motivation and efficacy to change sleep, extending sleep duration, and regularizing sleep timing across the week. Sleep monitoring is proposed to last the same duration as the targeted intervention in this arm.
Receives: Behavioral: Targeted Approaches for Promoting Adolescent Sleep (TAPAS); Behavioral: Sleep Monitoring Only

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Attrition

    Participant attrition rate

    Measured: 4 weeks

  2. Response Rate

    Participant response rate to electronic intervention prompts

    Measured: 4 weeks

  3. Adherence

    A locally-developed Sleep Promotion Program Rating form indicates which program components covered in each clinician session. The measure is a checklist that indicates the presence or absence of each component covered in the session.

    Measured: 1 session

  4. Participant Satisfaction

    A locally-developed Treatment Satisfaction Questionnaire measures program satisfaction. Scores range from 18 to 75, with higher scores indicating greater satisfaction.

    Measured: 4 weeks

  5. Sleep Diary Sleep Duration

    Average sleep duration (in hours and minutes) as measured by sleep diary

    Measured: 4 weeks

  6. Sleep Diary Sleep Timing

    Average sleep timing as measured by sleep diary

    Measured: 4 weeks

  7. Sleep Diary Weekend-Weekday Sleep Timing Differences

    Difference in average weekend and weekday sleep timing as measured by sleep diary

    Measured: 4 weeks

Secondary outcomes (3)
  1. Actigraphy Sleep Duration

    Average sleep duration (in hours and minutes) as measured by actigraphy

    Measured: 4 weeks

  2. Actigraphy Sleep Timing

    Average sleep timing as measured by actigraphy

    Measured: 4 weeks

  3. Actigraphy Weekend-Weekday Sleep Timing Differences

    Differences in average weekend and weekday sleep timing as measured by actigraphy

    Measured: 4 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Nov 2019
  2. Study start24 Oct 2019
  3. Primary completion25 Aug 2022
  4. Study completion25 Aug 2022

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Model description
Among those with insufficient sleep, after participants are screened and receive universal education about sleep, those with insufficient sleep will be offered to participate in the randomized pilot trial. There are two arms in the randomized trial: TAPAS intervention, and wait-list control (monitoring only). The study will enroll n=50 participants in the Randomized Control Trial (RCT) to obtain full data on n=40 participants after attrition. Participants who obtain sufficient sleep will not be randomized, but will obtain the universal education only. Investigators anticipate enrolling n=35 adolescents with sufficient sleep.
Masking
None (open label)
Enrolment
82 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04163003
Sponsor's protocol ID
STUDY19080033
Other IDs
K23HD087433
Acronym
TAPAS
Status last verified
Oct 2022
First submitted
24 Sep 2019
Last updated
12 Oct 2022
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Wescott DL, Goldstein TR, Wallace ML, Miller E, Buysse DJ, Harvey A, Suffoletto B, Rofey DL, Levenson JC. Effects of a single session intervention on actigraphy-measured sleep for adolescents with insufficient and irregular sleep: A randomized controlled trial. Sleep Health. 2026 Apr;12(2):333-339. doi: 10.1016/j.sleh.2025.12.008. Epub 2026 Jan 19.

    PubMed 41558877
  • Levenson JC, Goldstein TR, Wallace ML, Witt R, Harvey AG, Buysse D, Rofey DL, Suffoletto B, Miller E. A sleep promotion program for insufficient sleep among adolescents: a pilot feasibility randomized controlled trial. J Clin Sleep Med. 2025 Mar 1;21(3):529-541. doi: 10.5664/jcsm.11456.

    PubMed 39506293

Questions about this trial

What is this clinical trial studying?

A study testing Targeted Approaches for Promoting Adolescent Sleep (TAPAS) and Sleep Monitoring Only in people with Sleep Disturbance, run by University of Pittsburgh at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 17 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 12 Oct 2022. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Attrition (time frame: 4 weeks). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04163003, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Oct 2022; AzTrials last refreshed its copy on 27 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in